Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 5/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.36 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.36 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GGT1 | P19440 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GNPAT | O15228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21226 | 1.00 | KMT2A (0.43) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL627104 | 1.00 | KMT2A (0.43) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL910807 | 0.85 | FOLH1 (0.52) | KMT2ABLMFOLH1RIMKLANAALAD2 | |
| SCHEMBL910825 | 0.85 | FOLH1 (0.52) | KMT2ABLMFOLH1RIMKLANAALAD2 | |
| SCHEMBL910826 | 0.85 | FOLH1 (0.52) | KMT2ABLMFOLH1RIMKLANAALAD2 | |
| Hydrochloric Acid SCHEMBL8726781 | 0.84 | FOLH1 (0.50) | KMT2ABLMFOLH1RIMKLANAALAD2 | |
| Hydrochloric Acid SCHEMBL8726784 | 0.84 | FOLH1 (0.50) | KMT2ABLMFOLH1RIMKLANAALAD2 | |
| SCHEMBL27683390 | 0.84 | FOLH1 (0.50) | KMT2ABLMFOLH1RIMKLANAALAD2 | |
| SCHEMBL10972602 | 0.81 | ECE1 (0.39) | KMT2ACA2CA1TSHRMAPT | |
| SCHEMBL30787971 | 0.81 | GGT1 (0.43) | FOLH1RIMKLANAALAD2GGT1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217932-A1 | PYRIDIUM ESTERS | THE PROCTER AND GAMBLE COMPANY | 2024-07-04 | — | — | US | claimed |
| EP-4374698-A1 | PYRIDINIUM ESTERS | The Procter & Gamble Company (US) | 2024-05-29 | — | — | EP | claimed |
| WO-2023240103-A1 | ANTIMICROBIAL COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-14 | — | — | WO | claimed |
| WO-2023240102-A1 | ANTIMICROBIAL COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-14 | — | — | WO | claimed |
| EP-4289268-A1 | ANTIMICROBIAL COMPOSITION | The Procter & Gamble Company (US) | 2023-12-13 | — | — | EP | claimed |
| EP-4289269-A1 | ANTIMICROBIAL COMPOSITION | The Procter & Gamble Company (US) | 2023-12-13 | — | — | EP | claimed |
| US-20230389545-A1 | ANTIMICROBIAL COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2023-12-07 | — | — | US | claimed |
| US-20230389546-A1 | ANTIMICROBIAL COMPOSITION | THE PROCTER & GAMBLE COMPANY | 2023-12-07 | — | — | US | claimed |
| US-11793198-B2 | Disinfectant composition | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-24 | — | — | US | claimed |
| WO-2023158919-A1 | ANTIMICROBIAL COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2023-08-24 | — | — | WO | claimed |
| WO-2012027145-A1 | EMULSIONS CONTAINING SACCHARIDE SILOXANE COPOLYMER EMULSIFIERS AND METHODS FOR THEIR PREPARATION AND USE | DOW CORNING CORPORATION (US) | 2012-03-01 | — | — | WO | claimed |
| US-20120037565-A1 | Methods and Materials for Selective Boron Adsorption from Aqueous Solution | HYDRANAUTICS (US) | 2012-02-16 | — | — | US | claimed |
| EP-2074983-A2 | Method for preparing a cationic nanoemulsion and cosmetic composition | L'Oreal (FR) | 2009-07-01 | — | — | EP | claimed |
| EP-1782071-A2 | COVALENT TETHERING OF FUNCTIONAL GROUPS TO PROTEINS AND SUBSTRATES THEREFOR | PROMEGA CORPORATION (US) | 2007-05-09 | — | — | EP | claimed |
| US-20070087400-A1 | Covalent tethering of functional groups to proteins and substrates therefor | PROMEGA CORPORATION | 2007-04-19 | — | — | US | claimed |
| WO-2006093529-A2 | COVALENT TETHERING OF FUNCTIONAL GROUPS TO PROTEINS AND SUBSTRATES THEREFOR | PROMEGA CORPORATION (US) | 2006-09-08 | — | — | WO | claimed |
| EP-1430867-A1 | Process to prepare a cationic nanoemulsion, and cosmetic composition. | L'OREAL (FR) | 2004-06-23 | — | — | EP | claimed |
| EP-0249245-A2 | Antihypertensive dihydropyridine derivatives | LABORATOIRES SYNTEX S.A. (FR) | 1987-12-16 | — | — | EP | claimed |
| US-4698432-A | Process for the resolution of (±) 2-[2'-(p-fluorophenyl)-5'-benzoxazolyl]-propionic acid | RAVIZZA SPA (IT) | 1987-10-06 | — | — | US | claimed |
| EP-0169302-A1 | Process for the resolution of (+) 2-/2'-(p-fluorophenyl)-5'-benzoxazolyl/-propionic acid | RAVIZZA S.p.A. (IT) | 1986-01-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070087400-A1 | Covalent tethering of functional groups to proteins and substrates therefor | WASF2, NOTUM, YIPF5 | KMT2A 2962/4885ALOX15 3754/4885BLM 3863/4885 |
| US-20120037565-A1 | Methods and Materials for Selective Boron Adsorption from Aqueous Solution | BDKRB1, HBB, SLC2A1 | KMT2A 1926/4885ALOX15 3394/4885BLM 364/4885 |
| US-11793198-B2 | Disinfectant composition | ALKBH1, ALKBH5, POLL | KMT2A 1033/4885ALOX15 2901/4885BLM 915/4885 |
| US-20240217932-A1 | PYRIDIUM ESTERS | C5, CBR3, CHRM1 | KMT2A 3425/4885ALOX15 528/4885BLM 3435/4885 |
| US-20230389545-A1 | ANTIMICROBIAL COMPOSITION | ARG1, CUTA, AAAS | KMT2A 4667/4885ALOX15 1248/4885BLM 2298/4885 |
| US-20230389546-A1 | ANTIMICROBIAL COMPOSITION | ARG1, CUTA, AAAS | KMT2A 4266/4885ALOX15 1394/4885BLM 3595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.